• FDA Seeks Safety Report on Repros Therapeutics Inc. (RPRX) Tumor Drug More...

• Genzyme Corporation (GENZ) Rare-disease Drug Denied Accelerated Decision by FDA More...

• Exelixis, Inc. (EXEL) Completes Submission of New Drug Application for Cabozantinib for the Treatment of Medullary Thyroid Cancer More...

• Ligand Pharmaceuticals Inc. (LGND) Partner GlaxoSmithKline (GSK) Submits US and European Regulatory Applications for use of PROMACTA/REVOLADE to Increase Platelet Counts in Patients with Hepatitis C More...

• Bristol-Myers Squibb Company (BMY) Drug Helps Body Attack Lung Cancer More...

• Antioxidant May Help Children With Autism, Stanford University Study More...

• Bananas Are as Beneficial as Sports Drinks, Appalachian State University Study More...

• PCB Exposure Linked to Increased Abdominal Fat, Uppsala University Study More...

• 21st Century Bloodletting Reduces Cardiovascular Risk, Charite-University Medical Centre Study More...

• FDA Warns Johnson & Johnson (JNJ) Over Vaginal Products More...

• FDA Warns Consumers About Fake Versions of Teva Pharmaceutical Industries Limited (TEVA)'s Adderall More...

• Perrigo Company (PRGO) Announces Tris Pharma, Inc. Final Approval of Tris Pharma, Inc.'s Dextromethorphan Polistirex Extended-Release Oral Suspension More...

• Alnylam Pharmaceuticals (ALNY) Lung Drug Fails Mid-stage Trial More...

• Flexion Therapeutics Reports Positive Data for Osteoarthritis Drug More...

• Celsion Corporation (CLN) Announces Completion of Enrollment in Its Pivotal Phase III HEAT Study of ThermoDox(R) in Primary Liver Cancer More...

• Exelixis, Inc. (EXEL) Initiates COMET-1 Pivotal Trial Focused on Overall Survival in Men With Advanced Prostate Cancer More...

• Bionor Pharma ASA Release: First Human Clinical Study of HIV Vaccine Vacc-C5 Approved to Begin More...

• Cytune Pharma is Granted an EU Patent for Its Potent Immunotherapy CYP0150: an Optimized Recombinant Il-15 Fusion Protein and Will Attend BIO 2012 After a Year of Achievements More...

• Cytori Therapeutics, Inc. (CYTX) Obtains Celution(R) Approval in Russia; to Launch Product Line for Plastic Surgery and Select Soft Tissue Therapies More...

• MD Bioproducts Releases HLA-B27 Subtype Specific Antibody. More...

• STADA Arzneimittel AG (STAGn.DE) Cuts Jobs, Seeks Deals to Survive More...

• Intelliject, Inc. Announces $15 Million Debt Financing to Accelerate Targeted Pipeline Development More...

• AcelRx Pharmaceuticals Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing More...

• Bristol-Myers Squibb Company (BMY) Forms Global Academic Cancer Collaborations More...

• Ardea Biosciences, Inc. Earns $7.5 Million Milestone From Bayer HealthCare (BAY) More...

• CDRD and CDRD Ventures Inc. Enter into a Collaboration With GlaxoSmithKline (GSK) to Advance the Development and Commercialization of Canadian Health Research More...

• Ono Pharmaceutical Company, Ltd. and Galapagos NV (GLPG.BR) Subsidiary BioFocus DPI Sign an Additional Target Discovery Agreement in the Field of Allergic Disease More...

• Dyax Corp. (DYAX) Announces Extension of Partnership with Bayer Corporation (BAY) for Access to Dyax's Fully-Human Antibody Phage Display Library More...

• Akesis Names John L. Capicchioni as New President More...

• Alexander Tretyakov Joins PCI Synthesis as VP of Research and Development More...

• Former Stryker Corporation (SYK) Executive Robert Housler Jr. Joins InVivo Therapeutics as Vice President of Business Development More...

• Lance Stewart, Ph.D., M.B.A., Joins Allen Institute for Brain Science as Senior Director of Alliances More...

• Ember Therapeutics Expands Scientific Leadership to Advance Metabolic Pipeline More...

• Tikcro Technologies Reports 2012 First Quarter Results More...